-
1
-
-
4043143945
-
-
Department of Health, the Executive Yuan, Republic of China: Taipei Bureau of National Health Insurance; June
-
Department of Health, the Executive Yuan, Republic of China: National Health Insurance Annual Statistical Report, 2001. Taipei: Bureau of National Health Insurance; June 2002:314-5.
-
(2002)
National Health Insurance Annual Statistical Report, 2001
, pp. 314-315
-
-
-
2
-
-
0003626730
-
-
Organization for Economic Co-operation and Development: 4th edition 2002. Washington, DC: OECD
-
Organization for Economic Co-operation and Development: OECD Health Data 2002: A Comparative Analysis of 30 Countries. 4th edition, 2002. Washington, DC: OECD, 2002.
-
(2002)
OECD Health Data 2002: A Comparative Analysis of 30 Countries
-
-
-
3
-
-
0036249746
-
Acute upper airway infections
-
West JV: Acute upper airway infections. Br Med Bull 2002;61:215-30.
-
(2002)
Br. Med. Bull.
, vol.61
, pp. 215-230
-
-
West, J.V.1
-
4
-
-
0031030118
-
Evidence-based management of upper respiratoty infection in a family practice teaching clinic
-
English JA, Bauman KA: Evidence-based management of upper respiratoty infection in a family practice teaching clinic. Fam Med 1997;29:38-41.
-
(1997)
Fam. Med.
, vol.29
, pp. 38-41
-
-
English, J.A.1
Bauman, K.A.2
-
5
-
-
0008853111
-
Tylenol cold tablets (acetaminophen, chlorpheniramine, pseudoephedrine)
-
54th ed. Montvale, NJ: Medical Economics Company
-
Tylenol cold tablets (acetaminophen, chlorpheniramine, pseudoephedrine): Physicians' Desk Reference. 54th ed. Montvale, NJ: Medical Economics Company; 2000: 1676-7.
-
(2000)
Physicians' Desk Reference
, pp. 1676-1677
-
-
-
6
-
-
0033973035
-
Interethnic differences of drug-metabolizing enzymes
-
Gaedigk A: Interethnic differences of drug-metabolizing enzymes. Int J Clin Pharmacol Ther 2000;38:61-8.
-
(2000)
Int. J. Clin. Pharmacol. Ther.
, vol.38
, pp. 61-68
-
-
Gaedigk, A.1
-
7
-
-
0035916896
-
Principles of appropriate antibiotic use for treatment of nonspecific upper respiratory tract infections in adults
-
Snow V, Mottur-Pilson C, Gonzales R: Principles of appropriate antibiotic use for treatment of nonspecific upper respiratory tract infections in adults. Ann Intern Med 2001;143:487-9.
-
(2001)
Ann. Intern. Med.
, vol.143
, pp. 487-489
-
-
Snow, V.1
Mottur-Pilson, C.2
Gonzales, R.3
-
8
-
-
0031663421
-
Systematic review of the treatment upper respiratory tract infection
-
Fahey T, Stocks N, Thomas T: Systematic review of the treatment upper respiratory tract infection. Arch Dis Child 1998;79:225-30.
-
(1998)
Arch. Dis. Child
, vol.79
, pp. 225-230
-
-
Fahey, T.1
Stocks, N.2
Thomas, T.3
-
11
-
-
0003651256
-
-
Ed. 11th ed. Washington, DC: American Pharmaceutical Association. The National Professional Society of Pharmacists
-
Covington TR: Ed. Handbook of nonprescription drugs. 11th ed. Washington, DC: American Pharmaceutical Association. The National Professional Society of Pharmacists, 1996.
-
(1996)
Handbook of Nonprescription Drugs
-
-
Covington, T.R.1
-
12
-
-
4043108824
-
-
Humphrey-Durham Drug Prescription Act, Pub L No. 82-215. 65 Stat 648-649 (October 26,)
-
Humphrey-Durham Drug Prescription Act, Pub L No. 82-215. 65 Stat 648-649 (October 26, 1951).
-
(1951)
-
-
-
13
-
-
0025731444
-
Implications of reclassification of drugs from prescription-only to over-the-counter status
-
Gossel EA: Implications of reclassification of drugs from prescription-only to over-the-counter status. Clin Ther 1991;13:200-15.
-
(1991)
Clin. Ther.
, vol.13
, pp. 200-215
-
-
Gossel, E.A.1
-
14
-
-
0033092323
-
Who bears the burden of Medicaid drug copayment policies?
-
Stuart B, Zacker C: Who bears the burden of Medicaid drug copayment policies? Health Aff 1999;18:201-12.
-
(1999)
Health Aff.
, vol.18
, pp. 201-212
-
-
Stuart, B.1
Zacker, C.2
-
15
-
-
0025933465
-
Effects of Medicaid drug-payment limits on admission to hospitals and nursing homes
-
Soumerai SB, Ross-Degnan D, Avorn J, et al: Effects of Medicaid drug-payment limits on admission to hospitals and nursing homes. N Engl J Med 1991;325:1072-7.
-
(1991)
N. Engl. J. Med.
, vol.325
, pp. 1072-1077
-
-
Soumerai, S.B.1
Ross-Degnan, D.2
Avorn, J.3
-
16
-
-
0031279454
-
The effect of increased prescription drug cost-sharing on medical care utilization and expenses of elderly health maintenance organization members
-
Johnson RE, Goodman MJ, Hornbrook MC, et al: The effect of increased prescription drug cost-sharing on medical care utilization and expenses of elderly health maintenance organization members. Med Care 1997;35:1119-31.
-
(1997)
Med. Care
, vol.35
, pp. 1119-1131
-
-
Johnson, R.E.1
Goodman, M.J.2
Hornbrook, M.C.3
-
17
-
-
0025499636
-
The effect of drug co-payments on utilization and cost of pharmaceutics in a health maintenance organization
-
Harris BL, Stegachis A, Ried LD: The effect of drug co-payments on utilization and cost of pharmaceutics in a health maintenance organization. Med Care 1990;28:907-1017.
-
(1990)
Med. Care
, vol.28
, pp. 907-1017
-
-
Harris, B.L.1
Stegachis, A.2
Ried, L.D.3
-
18
-
-
0037048670
-
Employer drug benefit plans and spending on prescription drugs
-
Joyce GF, Escarce JJ, Solomon MD, et al: Employer drug benefit plans and spending on prescription drugs. JAMA 2002;288: 1733-9.
-
(2002)
JAMA
, vol.288
, pp. 1733-1739
-
-
Joyce, G.F.1
Escarce, J.J.2
Solomon, M.D.3
-
19
-
-
0035941514
-
Adverse events associated with prescription drug cost-sharing among poor and elderly persons
-
Tamblyn R, Laprise R, Hanley JA, et al: Adverse events associated with prescription drug cost-sharing among poor and elderly persons. JAMA 2001;285:421-9.
-
(2001)
JAMA
, vol.285
, pp. 421-429
-
-
Tamblyn, R.1
Laprise, R.2
Hanley, J.A.3
-
20
-
-
0035856022
-
Changing the status of drugs from prescription to over-the-counter availability
-
Brass EP: Changing the status of drugs from prescription to over-the-counter availability. N Engl J Med 2001;345:810-6.
-
(2001)
N. Engl. J. Med.
, vol.345
, pp. 810-816
-
-
Brass, E.P.1
|